Has Eleanor Eades received payments from drug or device companies?

Yes. Drug and device makers reported $2,138 in general payments to Eleanor Eades across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eleanor Eades did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eleanor Eades come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eleanor Eades

Neonatal-Perinatal Medicine · Savannah, GANPI 1639132376

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by CSL Behring at 38.2% of the total. Reporting peaked in 2020 at $633 and has fallen 80.3% since, to $125 in 2025. Among neonatal-perinatal medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,138in general payments, 2019–2025

Across 97 payments — averaging $22.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CSL Behring$817
Pharming Healthcare, Inc.$326
Octapharma USA, Inc.$257
GSK$162
Kaleo, Inc.$108
AstraZeneca$65
plus $403 from 12 others

What the payments were for

Food & beverage$2,138100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CSL Behring	40	$817
Pharming Healthcare, Inc.	11	$326
Octapharma USA, Inc.	5	$257
GSK	9	$162
Kaleo, Inc.	6	$108
AstraZeneca	4	$65
Teva Pharmaceuticals USA, Inc.	4	$63
Sanofi	3	$50
Genentech USA, Inc.	2	$43
Optinose US, Inc.	2	$38
Regeneron Healthcare Solutions, Inc.	2	$37
Biocryst US Sales Co., LLC	2	$34
Phadia US Inc.	2	$28
ADMA Biomanufacturing LLC	1	$27
AbbVie	1	$24
Boehringer Ingelheim	1	$23
Hospira, Inc.	1	$19
Hikma Pharmaceuticals USA	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RUCONEST$125

How this compares

$2,138 in reported general payments places this provider in the 95th percentile of 86 neonatal-perinatal medicine providers in Georgia.

See all neonatal-perinatal medicine providers in Georgia →

Other neonatal-perinatal medicine in Savannah

Ann SimoninSavannah$35
Benjamin MackowiakSavannah$35
Atul KhuranaAthens$9K
Sarah KeeneAtlanta$4K
Laura DrohanAtlanta$3K
Bharath SrivatsaAtlanta$2K
Santanu DasWarner Robins$699
Cynthia CabreraGainesville$374
Amy ThompsonAugusta$314
David CarltonAtlanta$311

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →